| 000 | 01782 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515161415.0 | ||
| 264 | 0 | _c20090528 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a1098-1004 | ||
| 024 | 7 |
_a10.1002/humu.20933 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPros, Eva | |
| 245 | 0 | 0 |
_aAntisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations. _h[electronic resource] |
| 260 |
_bHuman mutation _cMar 2009 |
||
| 300 |
_a454-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlternative Splicing |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aFibroblasts _xcytology |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntrons _xgenetics |
| 650 | 0 | 4 |
_aMorpholines _xchemistry |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeurofibromatosis 1 _xgenetics |
| 650 | 0 | 4 |
_aNeurofibromin 1 _xgenetics |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides, Antisense _xchemistry |
| 650 | 0 | 4 |
_aRNA Splice Sites _xgenetics |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aras Proteins _xmetabolism |
| 700 | 1 | _aFernández-Rodríguez, Juana | |
| 700 | 1 | _aCanet, Belén | |
| 700 | 1 | _aBenito, Llúcia | |
| 700 | 1 | _aSánchez, Aurora | |
| 700 | 1 | _aBenavides, Ana | |
| 700 | 1 | _aRamos, Feliciano J | |
| 700 | 1 | _aLópez-Ariztegui, María Asunción | |
| 700 | 1 | _aCapellá, Gabriel | |
| 700 | 1 | _aBlanco, Ignacio | |
| 700 | 1 | _aSerra, Eduard | |
| 700 | 1 | _aLázaro, Conxi | |
| 773 | 0 |
_tHuman mutation _gvol. 30 _gno. 3 _gp. 454-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/humu.20933 _zAvailable from publisher's website |
| 999 |
_c18683363 _d18683363 |
||